Amplifications and deletions in the GBM data.

Aberrant regions determined by the entropy method. These tables do not include regions for which more then half of the DNA probes were annotated as normal CNV. Candidate oncogenes / suppressors were selected by their potential association with cancer based on their molecular function or for being the only gene in the region. The genomic mapping was based on Build 18. The calling for amplifications and deletions was made by observing which amplitude measure, QQ0.025 (deletion) or 1-QQ0.975 (amplification), was closer to 0.*Not described or validated as oncogene or tumor suppressor in previous studies.